Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
120 participants
INTERVENTIONAL
2026-06-01
2028-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
NCT03256539
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
NCT01586039
Dose-dependent Impact of Daytime Lighting on Evening Responses to Light
NCT04882280
Bright Light as a Countermeasure for Circadian Desynchrony
NCT01119365
Light Exposure to Treat Sleep Disruption in Older People
NCT00427323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care
One hour of daily bright light exposure beginning one hour after wake time.
Light therapy
One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor
Stepped care
One hour of daily bright light exposure in the afternoon
Light therapy
One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Light therapy
One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>65
Exclusion Criteria
* Unstable psychiatric or medical disease
* Acute infection
65 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie M. Zeitzer, Ph.D.
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Redwood City, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-71788
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.